It certainly will encourage more people to sue. This is going to be a decade-long process. It's probably going to make Merck reserve more money.

Getting larger really does matter. Scale helps because it helps drive greater discounts. The more enrollees you have, the better off you are in terms of costs.

They're getting rid of unnecessary things and using the money to fund research and development.

For Pfizer, it offers some hope for the future that they can get novel products to market. This proves that they have drug development capability and points to a brighter future 18 months out.

When you start seeing these big, big products coming off patent, there's plenty for most of them to cut. It is quite possible that all of them have plenty more to cut if they want to.

It's not just the Cleveland Clinic.